---
title: "What the Largest ADHD Evidence Review Says Actually Works"
slug: adhd-largest-evidence-review-2026
category: health
category_label: "Health"
author: "BrainWavePost Staff"
date: 2026-02-12
tags: ["adhd", "mental health", "research"]
read_time_minutes: 6
canonical_url: https://brainwavepost.com/article/adhd-largest-evidence-review-2026
source: BrainWavePost
---

# What the Largest ADHD Evidence Review Says Actually Works

*Health · 2026-02-12 · BrainWavePost Staff · 6 min read*

> A landmark umbrella review published in The BMJ pulled together more than 200 meta-analyses on ADHD treatments. Here is a calm, plain-English summary of what the evidence supports — and where it is still thin.

A new umbrella review published in The BMJ has examined more than 200 meta-analyses of ADHD treatments, making it one of the most extensive evaluations of the evidence on attention-deficit/hyperactivity disorder (ADHD) to date.

The work was led by researchers from Université Paris Nanterre (France), Institut Robert-Debré du Cerveau de l’Enfant (France), and the University of Southampton (UK), and was funded by public, peer-reviewed grants. The findings were summarised by ScienceDaily and the University of Southampton on 10 February 2026.

> **Why this study matters** _(note)_
>
> An umbrella review pools results from many earlier meta-analyses, giving a high-level view of what the overall evidence base says. With more than 200 meta-analyses considered, this is one of the broadest looks at ADHD treatments ever published.

## What the review found

Across the studies analysed, medication remained the most reliably supported treatment for both children and adults with ADHD. For adults, cognitive behavioural therapy (CBT) was also strongly supported, with relatively solid short-term evidence.

- Five medications used in children and adolescents had strong supporting evidence.
- In adults, two medications and CBT showed effectiveness with relatively solid evidence.
- These findings were limited to short-term outcomes, even though treatment is often long-term.
- Other approaches such as acupuncture, mindfulness, and exercise showed signs of potential benefit, but were generally backed by lower-quality evidence.

## A new public tool for shared decisions

Alongside the review, the team launched a free, interactive website — ebiadhd-database.org — designed to help people with ADHD and their clinicians compare treatment options and see how strong the supporting evidence is for each one.

> We know that people with ADHD and their families are often overwhelmed by conflicting messages about which treatments work. We believe this study and the accompanying website provide the most authoritative, evidence-based, and accessible guidance currently available.
>
> — Professor Samuele Cortese, University of Southampton (via ScienceDaily)

## What the review does not claim

The authors are careful not to oversell the findings. While medication and adult CBT have the strongest short-term evidence, the review highlights a major gap: most high-quality data only covers short-term outcomes, even though many people receive treatment for years.

Lower-quality studies on approaches like mindfulness, exercise, and CBT in children were noted as potentially promising in some cases, but the team flagged small sample sizes and risk of bias as limits on how confidently those results can be interpreted.

## How this fits with existing guidelines

Overall, the review’s conclusions align closely with existing international clinical guidelines for ADHD. The team’s aim is not to overturn current recommendations, but to make the underlying evidence easier to access and to support shared decision-making between patients and clinicians.

ADHD treatment is a deeply personal decision that should be made with a qualified healthcare professional. This article is a summary of newly published research and is not medical advice.

> **Source credit** _(info)_
>
> This article is based on reporting by ScienceDaily (10 February 2026), which summarised research led by Université Paris Nanterre, Institut Robert-Debré du Cerveau de l’Enfant, and the University of Southampton, published in The BMJ as ‘Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making’ (BMJ 2025;391:e085875, DOI: 10.1136/bmj-2025-085875).

> **Read the original sources** _(tip)_
>
> Full ScienceDaily summary: sciencedaily.com/releases/2026/02/260208233825.htm — Interactive evidence platform: ebiadhd-database.org — Journal article: dx.doi.org/10.1136/bmj-2025-085875

> **About this article** _(note)_
>
> BrainWavePost may use AI tools to help research, draft, and structure articles. All published content is reviewed by our editorial team. Medical content is intended for general information only and is not a substitute for professional medical advice.

---

_Canonical article: [https://brainwavepost.com/article/adhd-largest-evidence-review-2026](https://brainwavepost.com/article/adhd-largest-evidence-review-2026) — © BrainWavePost. Educational content; see the article page for full disclaimers._